# Eltrombopag for Peripheral Blood Stem Cell Harvest

> **NCT05961410** · PHASE2 · RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 46 (estimated)

## Conditions studied

- Lymphoma
- Peripheral Blood Stem Cell Transplantation

## Interventions

- **DRUG:** Eltrombopag olamine

## Key facts

- **NCT ID:** NCT05961410
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-15
- **Primary completion:** 2025-03-31
- **Final completion:** 2026-03-01
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2024-10-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05961410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05961410, "Eltrombopag for Peripheral Blood Stem Cell Harvest". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05961410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*